Jiangsu Hengrui Medicine (600276.SS) Profit Metrics

Price: $46.23
Market Cap: $293.53B
Avg Volume: 35.56M
Country: CN
Industry: Drug Manufacturers - General
Sector: Healthcare
Beta: 0.265
52W Range: $37.24-57.53
Website: Jiangsu Hengrui Medicine
Profit Metrics Summary (Annual)

According to Jiangsu Hengrui Medicine 's latest annual financial reports:

  • The company has reported a gross profit of 19.29B, indicating the amount earned after deducting the cost of goods sold (COGS) from revenue. The gross profit margin is 84.55%, with a year-over-year growth of 8.47%.
  • Jiangsu Hengrui Medicine 's EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 5.54B. The EBITDA margin stands at 24.28%, showing a growth of 18.30% compared to the previous year.
  • The operating income, representing the profit from business operations before taxes and interest, stands at 4.91B. The operating margin is 21.52%, with a year-over-year growth of 19.41%.
  • The net income, which shows the company's total earnings or profit after all expenses, is 4.30B. The net profit margin is 18.85%, demonstrating a growth of 10.14% from the previous year.

These metrics provide a comprehensive overview of Jiangsu Hengrui Medicine 's profitability and operational efficiency over the past year.

Gross Profit

$19.29B

Gross Profit Margin (2023)

84.55%

EBITDA

$5.54B

EBITDA Margin

24.28%

Operating Income (2023)

$4.91B

Operating Margin

21.52%

Net Income

$4.30B

Net Profit Margin

18.85%

Historical Gross Profit
$30.00B$30.00B$24.00B$24.00B$18.00B$18.00B$12.00B$12.00B$6.00B$6.00B$0.00$0.00Gross Profit20052005200620062007200720082008200920092010201020112011201220122013201320142014201520152016201620172017201820182019201920202020202120212022202220232023
Historical Gross Profit Margin
87.93%87.93%70.34%70.34%52.76%52.76%35.17%35.17%17.59%17.59%0.00%0.00%Gross Profit Margin2005200520062006200720072008200820092009201020102011201120122012201320132014201420152015201620162017201720182018201920192020202020212021202220222023202320242024
Historical Gross Profit Growth
40.93%40.93%28.79%28.79%16.66%16.66%4.53%4.53%-7.61%-7.61%-19.74%-19.74%Gross Profit Growth2005200520062006200720072008200820092009201020102011201120122012201320132014201420152015201620162017201720182018201920192020202020212021202220222023202320242024
Historical EBITDA
$8.00B$8.00B$6.00B$6.00B$4.00B$4.00B$2.00B$2.00B$0.00$0.00EBITDA20052005200620062007200720082008200920092010201020112011201220122013201320142014201520152016201620172017201820182019201920202020202120212022202220232023
Historical EBITDA Margin
38.49%38.49%30.79%30.79%23.09%23.09%15.39%15.39%7.70%7.70%0.00%0.00%EBITDA Margin2005200520062006200720072008200820092009201020102011201120122012201320132014201420152015201620162017201720182018201920192020202020212021202220222023202320242024
Historical EBITDA Growth
57.13%57.13%39.31%39.31%21.50%21.50%3.69%3.69%-14.13%-14.13%-31.94%-31.94%EBITDA Growth2005200520062006200720072008200820092009201020102011201120122012201320132014201420152015201620162017201720182018201920192020202020212021202220222023202320242024
Historical Operating Income
$8.00B$8.00B$6.00B$6.00B$4.00B$4.00B$2.00B$2.00B$0.00$0.00Operating Income20052005200620062007200720082008200920092010201020112011201220122013201320142014201520152016201620172017201820182019201920202020202120212022202220232023
Historical Operating Profit Margin
27.52%27.52%22.02%22.02%16.51%16.51%11.01%11.01%5.50%5.50%0.00%0.00%Operating Profit Margin2005200520062006200720072008200820092009201020102011201120122012201320132014201420152015201620162017201720182018201920192020202020212021202220222023202320242024
Historical Operating Income Growth
122.78%122.78%70.71%70.71%18.64%18.64%-33.43%-33.43%Operating Income Growth2005200520062006200720072008200820092009201020102011201120122012201320132014201420152015201620162017201720182018201920192020202020212021202220222023202320242024
Historical Net Income
$8.00B$8.00B$6.00B$6.00B$4.00B$4.00B$2.00B$2.00B$0.00$0.00Net Income20052005200620062007200720082008200920092010201020112011201220122013201320142014201520152016201620172017201820182019201920202020202120212022202220232023
Historical Net Profit Margin
23.34%23.34%18.67%18.67%14.00%14.00%9.34%9.34%4.67%4.67%0.00%0.00%Net Profit Margin2005200520062006200720072008200820092009201020102011201120122012201320132014201420152015201620162017201720182018201920192020202020212021202220222023202320242024
Historical Net Income Growth
140.14%140.14%83.96%83.96%27.77%27.77%-28.41%-28.41%Net Income Growth2005200520062006200720072008200820092009201020102011201120122012201320132014201420152015201620162017201720182018201920192020202020212021202220222023202320242024
Jiangsu Hengrui Medicine Historical Profit Metrics
Gross Profit
EBITDA
Operating Income
Net Income
$30.00B$30.00B$24.00B$24.00B$18.00B$18.00B$12.00B$12.00B$6.00B$6.00B$0.00$0.00Profit Metrics20052005200620062007200720082008200920092010201020112011201220122013201320142014201520152016201620172017201820182019201920202020202120212022202220232023
Jiangsu Hengrui Medicine Historical Profits

The table below shows various profit metrics for each year, with the latest data available for the last fiscal year 2023.

Year Gross Profit Gross Profit Growth Operating Income Operating Income Growth Net Income Net Income Growth EBITDA EBITDA Growth
2023 $19.29B 8.47% $4.91B 19.41% $4.30B 10.14% $5.54B 18.30%
2022 $17.79B -19.74% $4.11B -11.85% $3.91B -13.77% $4.68B -6.73%
2021 $22.16B -9.11% $4.66B -33.43% $4.53B -28.41% $5.02B -31.94%
2020 $24.39B 19.68% $7.01B 13.94% $6.33B 18.78% $7.38B 10.42%
2019 $20.38B 35.09% $6.15B 33.79% $5.33B 31.05% $6.68B 36.72%
2018 $15.08B 25.84% $4.60B 20.72% $4.07B 26.39% $4.89B 20.27%
2017 $11.99B 24.09% $3.81B 25.91% $3.22B 24.25% $4.06B 24.24%
2016 $9.66B 21.59% $3.02B 18.19% $2.59B 19.22% $3.27B 24.09%
2015 $7.94B 29.41% $2.56B 44.37% $2.17B 43.28% $2.64B 38.35%
2014 $6.14B 21.69% $1.77B 22.15% $1.52B 22.41% $1.90B 19.32%
2013 $5.04B 10.52% $1.45B 11.60% $1.24B 14.92% $1.60B 7.90%
2012 $4.56B 21.20% $1.30B 25.94% $1.08B 22.90% $1.48B 27.06%
2011 $3.77B 20.00% $1.03B 22.15% $876.61M 21.05% $1.16B 25.04%
2010 $3.14B 25.29% $845.21M 9.52% $724.17M 8.78% $931.34M 10.22%
2009 $2.51B 25.78% $771.72M 71.61% $665.73M 57.40% $844.96M 19.54%
2008 $1.99B 22.24% $449.71M -11.41% $422.95M 2.43% $706.82M 57.13%
2007 $1.63B 40.93% $507.64M 75.20% $412.92M 99.82% $449.84M 28.20%
2006 $1.16B 21.78% $289.75M 28.26% $206.65M 27.39% $350.89M 25.19%
2005 $949.35M 10.54% $225.90M 26.78% $162.22M 32.30% $280.28M 21.43%
2004 $858.82M 22.31% $178.18M 27.14% $122.62M 29.73% $230.81M 11.40%

Related Metrics

Explore detailed financial metrics and analysis for 600276.SS.

Financial Analysis
Financial Statements Stock Forecast Price Target Technical Analysis Stock Splits Employee Count
Company Intelligence
Ownership Insider Trading SEC Filings Congress Trading News Earnings Call Transcripts
Income & Revenue
Earnings Revenue Revenue Growth Profit Net Income Profit Margin EBITDA Free Cash Flow Revenue Segments
Valuation
Valuation Market Cap Enterprise Value P/E Ratio PEG Ratio P/S Ratio P/B Ratio Book Value
Returns & Ratios
ROIC ROE ROA Current Ratio Quick Ratio Debt/Equity Ratio Earnings Per Share
Balance Sheet
Assets Debt Cash On Hand Shares Outstanding
Dividends
Dividends Dividend Yield Payout Ratio